Literature DB >> 21917987

Native α6β4* nicotinic receptors control exocytosis in human chromaffin cells of the adrenal gland.

Alberto Pérez-Alvarez1, Alicia Hernández-Vivanco, J Michael McIntosh, Almudena Albillos.   

Abstract

In the present study, we have electrophysiologically characterized native nicotinic acetylcholine receptors (nAChRs) in human chromaffin cells of the adrenal gland as well as their contribution to the exocytotic process. α-Conotoxin AuIB blocked by 14 ± 1% the acetylcholine (ACh)-induced nicotinic current. α-Conotoxin MII (α-Ctx MII) exhibited an almost full blockade of the nicotinic current at nanomolar concentrations (IC(50)=21.6 nM). The α6*-preferring α-Ctx MII mutant analogs, α-Ctx MII[H9A,L15A] and α-Ctx MII[S4A,E11A,L15A], blocked nAChR currents with an IC(50) of 217.8 and 33 nM, respectively. These data reveal that nAChRs in these cells include the α6* subtype. The washout of the blockade exerted by α-conotoxin BuIA (α-Ctx BuIA; 1 μM) on ACh-evoked currents was slight and slow, arguing in favor of the presence of a β4 subunit in the nAChR composition. Exocytosis was almost fully blocked by 1 μM α-Ctx MII, its mutant analogs, or α-Ctx BuIA. Finally, the fluorescent analog Alexa Fluor 546-BuIA showed distinct staining in these cells. Our results reveal that α6β4* nAChRs are expressed and contribute to exocytosis in human chromaffin cells of the adrenal gland, the main source of adrenaline under stressful situations.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21917987      PMCID: PMC3250250          DOI: 10.1096/fj.11-190223

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  64 in total

1.  Molecular biology and electrophysiology of neuronal nicotinic receptors of rat chromaffin cells.

Authors:  Silvia Di Angelantonio; Cosetta Matteoni; Elsa Fabbretti; Andrea Nistri
Journal:  Eur J Neurosci       Date:  2003-06       Impact factor: 3.386

2.  Alpha-conotoxin PIA is selective for alpha6 subunit-containing nicotinic acetylcholine receptors.

Authors:  Cheryl Dowell; Baldomero M Olivera; James E Garrett; Sarah T Staheli; Maren Watkins; Alexander Kuryatov; Doju Yoshikami; Jon M Lindstrom; J Michael McIntosh
Journal:  J Neurosci       Date:  2003-09-17       Impact factor: 6.167

3.  Determinants of specificity for alpha-conotoxin MII on alpha3beta2 neuronal nicotinic receptors.

Authors:  S C Harvey; J M McIntosh; G E Cartier; F N Maddox; C W Luetje
Journal:  Mol Pharmacol       Date:  1997-02       Impact factor: 4.436

4.  Expression of neuronal nicotinic acetylcholine receptor subunit mRNAs within midbrain dopamine neurons.

Authors:  Layla Azam; Ursula H Winzer-Serhan; Yiling Chen; Frances M Leslie
Journal:  J Comp Neurol       Date:  2002-03-12       Impact factor: 3.215

5.  Vulnerability of 125I-alpha-conotoxin MII binding sites to nigrostriatal damage in monkey.

Authors:  M Quik; Y Polonskaya; J M Kulak; J M McIntosh
Journal:  J Neurosci       Date:  2001-08-01       Impact factor: 6.167

6.  Expression of nicotinic acetylcholine receptors in human and rat adrenal medulla.

Authors:  M Mousavi; E Hellström-Lindahl; Z Z Guan; I Bednar; A Nordberg
Journal:  Life Sci       Date:  2001-12-21       Impact factor: 5.037

7.  Functional nicotinic acetylcholine receptors that mediate ganglionic transmission in cardiac parasympathetic neurons.

Authors:  S Bibevski; Y Zhou; J M McIntosh; R E Zigmond; M E Dunlap
Journal:  J Neurosci       Date:  2000-07-01       Impact factor: 6.167

8.  Dorsal root ganglion neurons express multiple nicotinic acetylcholine receptor subtypes.

Authors:  J R Genzen; W Van Cleve; D S McGehee
Journal:  J Neurophysiol       Date:  2001-10       Impact factor: 2.714

9.  Analogs of alpha-conotoxin MII are selective for alpha6-containing nicotinic acetylcholine receptors.

Authors:  J Michael McIntosh; Layla Azam; Sarah Staheli; Cheryl Dowell; Jon M Lindstrom; Alexander Kuryatov; James E Garrett; Michael J Marks; Paul Whiteaker
Journal:  Mol Pharmacol       Date:  2004-04       Impact factor: 4.436

10.  Distribution and pharmacology of alpha 6-containing nicotinic acetylcholine receptors analyzed with mutant mice.

Authors:  Nicolas Champtiaux; Zhi-Yan Han; Alain Bessis; Francesco Mattia Rossi; Michele Zoli; Lisa Marubio; J Michael McIntosh; Jean-Pierre Changeux
Journal:  J Neurosci       Date:  2002-02-15       Impact factor: 6.167

View more
  18 in total

1.  Elucidation of molecular impediments in the α6 subunit for in vitro expression of functional α6β4* nicotinic acetylcholine receptors.

Authors:  Anne B Jensen; Kirsten Hoestgaard-Jensen; Anders A Jensen
Journal:  J Biol Chem       Date:  2013-10-01       Impact factor: 5.157

2.  Roles for N-terminal extracellular domains of nicotinic acetylcholine receptor (nAChR) β3 subunits in enhanced functional expression of mouse α6β2β3- and α6β4β3-nAChRs.

Authors:  Bhagirathi Dash; Ming D Li; Ronald J Lukas
Journal:  J Biol Chem       Date:  2014-07-15       Impact factor: 5.157

3.  α-Conotoxin PeIA[S9H,V10A,E14N] potently and selectively blocks α6β2β3 versus α6β4 nicotinic acetylcholine receptors.

Authors:  Arik J Hone; Mick'l Scadden; Joanna Gajewiak; Sean Christensen; Jon Lindstrom; J Michael McIntosh
Journal:  Mol Pharmacol       Date:  2012-08-22       Impact factor: 4.436

Review 4.  Human nicotinic receptors in chromaffin cells: characterization and pharmacology.

Authors:  Almudena Albillos; J Michael McIntosh
Journal:  Pflugers Arch       Date:  2017-10-20       Impact factor: 3.657

5.  Nicotinic acetylcholine receptors in dorsal root ganglion neurons include the α6β4* subtype.

Authors:  Arik J Hone; Erin L Meyer; Melissa McIntyre; J Michael McIntosh
Journal:  FASEB J       Date:  2011-10-24       Impact factor: 5.191

Review 6.  Functional chromaffin cell plasticity in response to stress: focus on nicotinic, gap junction, and voltage-gated Ca2+ channels.

Authors:  Nathalie C Guérineau; Michel G Desarménien; Valentina Carabelli; Emilio Carbone
Journal:  J Mol Neurosci       Date:  2012-01-18       Impact factor: 3.444

7.  α-Conotoxin VnIB from Conus ventricosus is a potent and selective antagonist of α6β4* nicotinic acetylcholine receptors.

Authors:  Marloes van Hout; Amanda Valdes; Sean B Christensen; Phuong T Tran; Maren Watkins; Joanna Gajewiak; Anders A Jensen; Baldomero M Olivera; J Michael McIntosh
Journal:  Neuropharmacology       Date:  2019-06-28       Impact factor: 5.250

Review 8.  Nerve Stimulation: Immunomodulation and Control of Inflammation.

Authors:  Luis Ulloa; Salvador Quiroz-Gonzalez; Rafael Torres-Rosas
Journal:  Trends Mol Med       Date:  2017-11-20       Impact factor: 11.951

9.  α-Conotoxins Identify the α3β4* Subtype as the Predominant Nicotinic Acetylcholine Receptor Expressed in Human Adrenal Chromaffin Cells.

Authors:  Arik J Hone; J Michael McIntosh; Layla Azam; Jon Lindstrom; Linda Lucero; Paul Whiteaker; Juan Passas; Jesús Blázquez; Almudena Albillos
Journal:  Mol Pharmacol       Date:  2015-09-01       Impact factor: 4.436

Review 10.  Diverse strategies targeting α7 homomeric and α6β2* heteromeric nicotinic acetylcholine receptors for smoking cessation.

Authors:  Darlene H Brunzell; J Michael McIntosh; Roger L Papke
Journal:  Ann N Y Acad Sci       Date:  2014-04-14       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.